Retatrutide (A Triple Agonist - GLP-1, GIP, and Glucagon) is an advanced metabolic peptide under clinical development. It activates three powerful hormone pathways to support aggressive fat loss, muscle preservation, and glycemic control. Users in trials reported weight loss exceeding 20% in under a year. This compound boosts energy usage, reduces appetite, and improves insulin response — making it one of the most potent next-gen peptides for physique enhancement and long-term metabolic correction.